Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Uncategorized » Blog article: New Lab Evidence Suggests Preventive Effect of Herbal Supplement in Prostate Cancer

New Lab Evidence Suggests Preventive Effect of Herbal Supplement in Prostate Cancer

This Article was Written February 27th, 2009

Powered by Gregarious (39)

New Lab Evidence Suggests Preventive

Effect Of Herbal Supplement In Prostate

Cancer

ScienceDaily (Feb. 23, 2009) — DHEA is a natural circulating hormone and the body’s production of it decreases with age. Men take DHEA as an over-the-counter supplement because it has been suggested that DHEA can reverse aging or have anabolic effects since it can be metabolized in the body to androgens. Increased consumption of dietary isoflavones is associated with a decreased risk of prostate cancer.


Red clover (Trifolium pretense) is one source of isoflavones. Both supplements may have hormonal effects in the prostate and little is known about the safety of these supplements.

In a recent report in Cancer Prevention Research, a journal of the American Association for Cancer Research, researchers report that DHEA levels can be manipulated in cells in the laboratory to understand its effects.

Julia Arnold, Ph.D., a staff scientist at the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health, said more research is necessary in an environment where men and women concerned about health problems tend to self-prescribe based on information they find on the Internet.

Towards this end, the NCCAM laboratory is studying signaling between human prostate cancer cells and their supporting stromal cells as they grow together in laboratory culture. “DHEA effects in the prostate tissues may depend on how these two cells types ‘talk to each other’ and further, it may be potentially harmful in tissues containing inflammation or with early cancer lesions because the cells can induce DHEA to become more androgenic,” said Arnold.

Combining DHEA with transforming growth factor beta-1 increased testosterone production in the stromal cells and prostate specific antigen protein secretion two to four-fold and gene expression up to 50-fold in the cancer cells. When these cell cultures were treated with red clover isoflavones, the androgenic effects of DHEA were reversed.

“Something is happening in the prostate tissue microenvironment that is illustrating a potential cancer prevention effect from this supplement,” said Arnold.

Red clover isoflavones may modify androgenic effects in the prostate but much more work in the laboratory and clinic is needed to validate these effects.

This sort of laboratory manipulation will allow scientists to understand the basic prostate biology as well as learn cellular and molecular mechanisms of over-the-counter supplements and other botanical or herbal agents. Arnold said NCCAM will continue to study DHEA with other supplements to determine any cancer preventive effects.


Adapted from materials provided by American Association for Cancer Research, via EurekAlert!, a service of AAAS.
Powered by Gregarious (39)

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Welcome to the Cancer Options blog!

  • With this blog our goal is to lay a foundation for a site that helps answer different questions about cancer, treatments, technologies and much more. You'll be able to find articles from how to cope with a severe diagnosis to all the cancer options you have as far as treatments
  • ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men

  • By Michael Smith, Senior Staff Writer, MedPage Today Published: October 31, 2007 Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine. LOS ANGELES, Oct. 31 -- Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.Younger age is often thought
  • Strikeout prostate cancer

  •  About one in six men is diagnosed with prostate cancer. If it's caught early, the cancer is almost 100-percent curable, but if it goes undetected, it can be deadly. So now a new campaign is raising money and getting guys attention . . . with America's favorite pasttime. As major league
  • ASTRO’s 49th annual meeting of radiation oncology

  • ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds' effectiveness in the treatment of prostate cancer--supporting and broadening the growing body of evidence on the newest medical isotope being
  • New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

  • ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient's treatment options, according to a study presented in a scientific session on September, 23, 2008, at
  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading

  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. Experiments reported in the journal Nature, the scientists
  • Prostate Cancer Hormone Therapy Treatment Questioned

  • Hormone therapy, an aggressive treatment for prostate cancer, may be overused, a new study suggests.Treatment used to reduce the size of the prostate has been shown to improve survival in advanced cancers, but doctors have increasingly been giving hormone therapy in less-severe cases. The study, published in this week's New England
  • Statins Lower Blood Marker for Prostate Cancer

  • But it's not clear if the cholesterol-lowering drugs protect against the disease Posted October 30, 2008 By Ed Edelson HealthDay Reporter  THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk. That drop
  • Legal Notices

  • IsoRay Medical, Inc. Website Terms Of Use Agreement And Disclaimer Of Liability Welcome to www.isoray.com (the “Website”). IsoRay Medical, Inc. and its affiliates (“we,” “us” or “IsoRay”) provide the information and content on this Website as a convenience and for general informational and educational purposes only. By accessing this Website, you, and any parties
  • Molecular Fingerprints Point The Way To Earlier Cancer Diagnosis And More Targeted Treatment

  • Molecular Fingerprints Point The Way To  Earlier Cancer Diagnosis And More Targeted Treatment ScienceDaily (Mar. 23, 2009) — Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.   You've likely heard about metabolites; your physician probably screens for some known ones


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031